Citations

Clear

1320 citation(s) found for "Nguyen, Vi".

[P4–074]: INTEGRATIVE SYSTEMS BIOLOGY APPROACH TO IDENTIFY NOVEL RISK FACTORS FOR PSP
Allen, Mariet , Wang, Xue , Younkin, Curtis, Serie, Daniel, Nguyen, Thuy , Lincoln, Sarah, Malphrus, Kimberly G., Carrasquillo, Minerva M. , Schellenberg, Gerard D. , Younkin, Steven G. , Asmann, Yan W. , Ertekin‐Taner, Nilüfer , Wang, Xue, Burgess, Jeremy D. , Carrasquillo, Minerva M. , Kouri, Naomi , Murray, Melissa E. , Crook, Julia E. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_26 | Pages: No page available

10.1016/j.jalz.2017.06.1939 Get It

[O2–13–03]: USING TISSUE‐BASED TRANSCRIPTOMICS TO PROFILE CELL TYPE VARIABILITY IN THE BRAIN
Allen, Mariet , Wang, Xue , Reddy, Joseph S. , Carrasquillo, Minerva M. , Younkin, Curtis, Funk, Cory C. , Nguyen, Thuy , Lincoln, Sarah, Malphrus, Kimberly G., Asmann, Yan W. , Younkin, Steven G. , Golde, Todd E. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Burgess, Jeremy D. , Price, Nathan D. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2017.07.218 Get It

[P3–455]: DETECTABLE NEUROPSYCHOLOGICAL DIFFERENCES IN EARLY PRECLINICAL ALZHEIMER's DISEASE: A META‐ANALYSIS
Han, Duke, Nguyen, Caroline, Nation, Daniel A. , Stricker, Nikki H.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_23 | Pages: No page available

10.1016/j.jalz.2017.06.1673 Get It

[P3–096]: NOVEL CANDIDATE AD‐RISK LOCI IDENTIFIED THROUGH WHOLE EXOME SEQUENCING IN AFRICAN‐AMERICANS
Carrasquillo, Minerva M. , Ho, Charlotte C.G. , N’Songo, Aurelie, Wang, Xue , Nguyen, Thuy , Bisceglio, Gina, Lincoln, Sarah, Malphrus, Kimberly G., Asmann, Yan W. , Younkin, Steven G., Duara, Ranjan , Custo, María T. Greig, Graff‐Radford, Neill R. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Burgess, Jeremy D. , Ma, Li , Duara, Ranjan

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_20 | Pages: No page available

10.1016/j.jalz.2017.06.1306 Get It

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Jun, Tomi , Yang, Ju Dong , Chen, Vincent , Nguyen, Pauline, Giama, Nasra H., Huang, Chung‐Feng , Hsing, Ann W. , Chuang, Wan‐Long , Roberts, Lewis R. , Yu, Ming‐Lung , Nguyen, Mindie H. , Nguyen, Mindie H , Roberts, Lewis R , Chen, V L , Yu, M-L , Yeh, Ming-Lun , Yang, Ju Dong , Dai, Chia-Yen , Huang, Jee‐Fu

Mayo Clinic

Liver International | October 16, 2017 | Volume: 38 | Issue: 5 | Pages: 895-902

10.1111/liv.13613 | PMID 29045023 Get It

AbstractBackground & AimsAlthough hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain major risk factors for hepatocellular carcinoma (HCC), non‐viral causes of HCC, particularly non‐alcoholic fatty liver disease (NAFLD), are becoming increasingly prevalent. The aim of this study was to compare the clinical characteristics and survival of cryptogenic and viral HCC.MethodsWe conducted a retrospective cohort study involving 3878 consecutive HCC patients seen at two tertiary centres in the United States and one in Taiwan from 2004 to 2014. We compared the clinical characteristics, treatment and survival of patients by underlying aetiology: cryptogenic (n = 696), HBV (n = 1304) or HCV (n = 1878).ResultsCirrhosis was present in 66.8% of the cryptogenic HCC patients, compared with 74.7% of HBV‐related HCC (HBV‐HCC) (P = .001) and 85.9% of HCV‐HCC (P < .001). Compared to viral HCC, cryptogenic HCC patients presented with larger tumours and at later stages of disease. Five‐year overall survival was 16.3% among cryptogenic HCC patients compared with 31.9% among HBV‐HCC patients and 27.7% among HCV‐HCC patients (P < .001 for both by the log‐rank test). HCC aetiology was not an independent predictor of survival, though ethnicity, cirrhosis status, meeting Milan criteria and treatment allocation were.ConclusionsCompared with viral HCC patients, those with cryptogenic HCC had lower prevalence of cirrhosis, were diagnosed with larger tumours at more advanced stages of disease, and had poorer overall survival. Additional efforts are needed to identify patients at risk of cryptogenic HCC and to identify cryptogenic HCC at earlier stages of disease.
Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma
Nguyen, Ba D.

Mayo Clinic

Journal of Gastroenterology and Hepatology | September 29, 2017 | Volume: 32 | Issue: 10 | Pages: 1667-1667

10.1111/jgh.13858 | PMID 28948701 Get It

Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis
Hasler, William L. , May, Kevin P. , Wilson, Laura , Natta, Mark L. Van , Parkman, Henry P. , Pasricha, Pankaj J. , Koch, Kenneth L. , Abell, Thomas L. , McCallum, Richard W. , Snape, William J., Sarosiek, Irene , Farrugia, Gianrico , Calles-Escandón, Jorge, Grover, Madhusudan , Tonascia, James , Lee, L. A., Miriel, Laura , Hamilton, Frank A., Hasler, W L , Parkman, H P , Abell, T L , Nguyen, Linda Anh B. , Clarke, John O.

Mayo Clinic

Neurogastroenterology & Motility | September 5, 2017 | Volume: 30 | Issue: 2 | Pages: No page available

10.1111/nmo.13196 | PMID 28872760 Get It

Abstract Background Wireless motility capsule ( WMC ) findings are incompletely defined in suspected gastroparesis. We aimed to characterize regional WMC transit and contractility in relation to scintigraphy, etiology, and symptoms in patients undergoing gastric emptying testing. Methods A total of 209 patients with gastroparesis symptoms at NIDDK Gastroparesis Consortium centers underwent gastric scintigraphy and WMC s on separate days to measure regional transit and contractility. Validated questionnaires quantified symptoms. Key Results Solid scintigraphy and liquid scintigraphy were delayed in 68.8% and 34.8% of patients; WMC gastric emptying times ( GET ) were delayed in 40.3% and showed 52.8% agreement with scintigraphy; 15.5% and 33.5% had delayed small bowel ( SBTT ) and colon transit ( CTT ) times. Transit was delayed in ≥2 regions in 23.3%. Rapid transit was rarely observed. Diabetics had slower GET but more rapid SBTT versus idiopathics ( P ≤ .02). GET delays related to greater scintigraphic retention, slower SBTT , and fewer gastric contractions ( P ≤ .04). Overall gastroparesis symptoms and nausea/vomiting, early satiety/fullness, bloating/distention, and upper abdominal pain subscores showed no relation to WMC transit. Upper and lower abdominal pain scores ( P ≤ .03) were greater with increased colon contractions. Constipation correlated with slower CTT and higher colon contractions ( P = .03). Diarrhea scores were higher with delayed SBTT and CTT ( P ≤ .04). Conclusions & Inferences Wireless motility capsules define gastric emptying delays similar but not identical to scintigraphy that are more severe in diabetics and relate to reduced gastric contractility. Extragastric transit delays occur in >40% with suspected gastroparesis. Gastroparesis symptoms show little association with WMC profiles, although lower symptoms relate to small bowel or colon abnormalities.
Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5
Nguyen, Tien, Barry, Mary , Turner, Mallory, Crosby, Catherine, Trujillo, Miguel, Morris, John, Barry, Michael, Barry, Michael A. , Turner, Mallory A., Crosby, Catherine M. , Trujillo, Miguel A., Barry, Michael A

Mayo Clinic

Biomedicines | August 10, 2017 | Volume: 5 | Issue: 3 | Pages: 46

10.3390/biomedicines5030046 | PMID 28796161 Get It

Oncolytic viruses would ideally be of use for systemic therapy to treat disseminated cancer. To do this safely, this may require multiple layers of cancer specificity. The pharmacology and specificity of oncolytic adenoviruses can be modified by (1) physical retargeting, (2) physical detargeting, (3) chemical shielding, or (4) by modifying the ability of viral early gene products to selectively activate in cancer versus normal cells. We explored the utility of these approaches with oncolytic adenovirus serotype 5 (Ad5) in immunocompetent Syrian hamsters bearing subcutaneous HaK tumors. After a single intravenous injection to reach the distant tumors, the physically hepatocyte-detargeted virus Ad5-hexon-BAP was more effective than conditionally replicating Ad5-dl1101/07 with mutations in its E1A protein. When these control or Ad5 treated animals were treated a second time by intratumoral injection, prior exposure to Ad5 did not affect tumor growth, suggesting that anti-Ad immunity neither prevented treatment nor amplified anti-tumor immune responses. Ad5-dl1101/07 was next chemically shielded with polyethylene glycol (PEG). While 5 kDa of PEG blunted pro-inflammatory IL-6 production induced by Ad5-dl1101/07, this shielding reduced Ad oncolytic activity.
Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options
Alkhawam, Hassan, Patel, Darshan , Nguyen, James , Easaw, Saumya, Al‐Sadawi, Mohammed , Syed, Umer , Zaiem, Feras, Homsi, Maher , Vittorio, Timothy J.

Mayo Clinic

Acta Cardiologica | July 14, 2017 | Volume: 72 | Issue: 4 | Pages: 380-389

10.1080/00015385.2017.1335034 | PMID 28705053 Get It

Early Markers of Angiogenesis and Ischemia during Bowel Conduit Neovascularization
Ciudad, Pedro , Torto, Federico Lo , Li, Yun-Fen , Nguyen, Doan-Minh, Chen, Hung‐Chi , Manrique, Oscar J. , Chen, Hung‐Chi , Wong, Alex K. , Chen, Pei‐Yu

Mayo Clinic

Journal of Reconstructive Microsurgery | June 19, 2017 | Volume: 33 | Issue: 09 | Pages: 605-611

10.1055/s-0037-1603905 | PMID 28628933 Get It

Background Bowel flaps are a good and reliable method to restore the continuity of the aerodigestive tract. Radiated fields, contaminated recipient sites, or depleted recipient vessels may increase the risk for ischemic injury after transfer. During ischemic events, we believe that bowel conduits with serosa have a delayed neovascularization process at its new recipient site.We conducted an ischemia/reperfusion murine model to understand the difference among bowel conduits with and without serosa. Materials and Methods Two groups of rats were compared: control group (jejunal conduit with serosa) and a target group (jejunal conduit without serosa). These conduits were harvested from the peritoneal cavity and transferred into a subcutaneous pocket. After 72 hours of transfer and pedicle ligation, histological changes related to ischemia/reperfusion were assessed. In addition, tissue markers of angiogenesis (CD34), ischemia (lactate dehydrogenase [LDH]), and inflammation (interleukin [IL]-1β and IL-6) were analyzed. Results Two groups (n = 20) of male rats were analyzed. Histology showed intact jejunal mucosa in the target group. The control group showed decreased number of mucin, globet cells, decreased height, and fragmentation of villi with the absence of intestinal glands. Markers of angiogenesis (CD34) were higher in the target group. In addition, markers of ischemia (LDH) (p = 0.0045) and inflammation (IL-1b, p = 0.0008, and IL-6, p = 0.0008) were significantly lower in the target group as compared with the control group. Conclusions In circumstances in which the recipient site does not offer an adequate and healthy bed or a vascular insult occurs, bowel flaps with less amount of serosa may be able to neovascularize faster thereby increasing its chances of survival.